HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Sept. 29, 2015 (HealthDay News) -- Best practice advice on diagnosis of suspected pulmonary embolism (PE) is provided for clinicians in clinical guidelines from the American College of Physicians (ACP). The guidelines were published online Sept. 29 in the Annals of Internal Medicine.
Ali S. Raja, M.D., from Massachusetts General Hospital in Boston, and colleagues provide practical advice for the evaluation of patients with suspected acute PE based on best available evidence and recent guidelines.
The researchers note that in order to estimate pretest probability of PE, clinicians should use validated clinical prediction rules. In patients with low pretest probability of PE and who meet all PE Rule-Out Criteria, clinicians should not obtain D-dimer measurements or imaging studies. In patients with an intermediate pretest probability of PE or with a low pretest probability who do not meet all PE Rule-Out Criteria, clinicians should obtain high-sensitivity D-dimer measurement as the initial diagnostic test. For patients older than 50 years, age-adjusted D-dimer thresholds should be used. In patients with a D-dimer level below the age-adjusted cut-off, clinicians should not obtain any imaging studies. In patients with high pretest probability of PE, clinicians should obtain imaging with computed tomography pulmonary angiography.
"ACP's advice is designed to help physicians identify patients for whom a PE is so unlikely that they need no further testing, for whom plasma D-dimer testing can provide additional risk stratification, and for whom imaging is indicated because of their high risk and clinical presentation," Wayne J. Riley, M.D., M.P.H., president of the ACP, said in a statement.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022